Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Essa Pharma (NQ: EPIX )

2.790 +0.040 (+1.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,981
Open 2.800
Bid (Size) 2.690 (2)
Ask (Size) 2.890 (2)
Prev. Close 2.750
Today's Range 2.690 - 2.869
52wk Range 1.400 - 5.160
Shares Outstanding 44,100,838
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ESSA Pharma: Q2 Earnings Insights
ESSA Pharma (NASDAQ:EPIX) reported its Q2 earnings results on Tuesday, May 9, 2023 at 07:00 AM. Here's what investors need to know about the announcement. Earnings ESSA Pharma beat estimated earnings... 
Via Benzinga
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are... 
Via Benzinga

Performance

YTD
+8.98%
+8.98%
1 Month
-3.46%
-3.46%
3 Month
-3.79%
-3.79%
6 Month
-8.82%
-8.82%
1 Year
+58.52%
+58.52%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Via Benzinga
ESSA Pharma Shares Tank As Janssen Stops Enrollment In EPI-7386 Combo Prostate Cancer Trials
Via Benzinga
$8.2 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Meta Platforms Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket
Via Benzinga
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
Via Benzinga
Nasdaq Drops Over 200 Points; Microsoft Shares Down After Q1 Results
Via Benzinga
Mullen (MULN) Stock Heats Up on Expanded Promotional Tour
Via InvestorPlace
Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Jumps Over 300 Points; Crude Oil Rises Sharply
Via Benzinga
ESSA Pharma And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
$1.7 Million Bet On This Biotechnology Stock? 3 Penny Stocks Insiders Are Buying
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
Via Benzinga
ESSA Pharma's EPI-7386 Monotherapy / Combo Therapy Show Early Activity Against Prostate Cancer
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
ESSA Pharma: Q2 Earnings Insights
Via Benzinga
ESSA Pharma Announces First Patient Dosed In Phase 1/2 Clinical Trial Of EPI-7386 In Combination With Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer
Via Benzinga
70 Biggest Movers From Friday
Via Benzinga
ESSA Pharma, Caris Life Sciences Ink Liquid Biopsy Profiling Pact
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.